FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3034988650> ?p ?o ?g. }

• W3034988650 endingPage "6958" @default.
• W3034988650 startingPage "6946" @default.
• W3034988650 abstract "Rationale: Transformed MUC1 (tMUC1) is a cancer-associated antigen that is overexpressed in >90% of triple-negative breast cancers (TNBC), a highly metastatic and aggressive subtype of breast cancer. TAB004, a murine antibody targeting tMUC1, has shown efficacy for the targeted delivery of therapeutics to cancer cells. Our aim was to evaluate humanized TAB004 (hTAB004) as a potential theranostic for TNBC. Methods: The internalization of hTAB004 in tMUC1 expressing HCC70 cells was assessed via fluorescent microscopy. hTAB004 was DOTA-conjugated and radiolabeled with Indium-111 or Actinium-225 and tested for stability and tMUC1 binding (ELISA, flow cytometry). Lastly, in vivo biodistribution (SPECT-CT), dosimetry, and efficacy of hTAB004 were evaluated using a TNBC orthotopic mouse model. Results: hTAB004 was shown to bind and internalize into tMUC1-expressing cells. A production method of 225Ac-DOTA-hTAB004 (yield>97%, RCP>97% SA=5 kBq/µg) and 111In-DOTA-hTAB004 (yield>70%, RCP>99%, SA=884 kBq/µg) was developed. The labeled molecules retained their affinity to tMUC1 and were stable in formulation and mouse serum. In NSG female mice bearing orthotopic HCC70 xenografts, the in vivo tumor concentration of 111In-DOTA-hTAB004 was 65 ± 15 %ID/g (120 h post injection). A single 225Ac-DOTA-hTAB004 dose (18.5 kBq) caused a significant reduction in tumor volume (P<0.001, day 22) and increased survival compared to controls (P<0.007). The human dosimetry results were comparable to other clinically used agents. Conclusion: The results obtained with hTAB004 suggest that the 111In/225Ac-DOTA-hTAB004 combination has significant potential as a theranostic strategy in TNBC and merits further development toward clinical translation." @default.
• W3034988650 created "2020-06-19" @default.
• W3034988650 creator A5006550201 @default.
• W3034988650 creator A5023904129 @default.
• W3034988650 creator A5031651482 @default.
• W3034988650 creator A5032595840 @default.
• W3034988650 creator A5034046647 @default.
• W3034988650 creator A5035756167 @default.
• W3034988650 creator A5045937236 @default.
• W3034988650 creator A5062378220 @default.
• W3034988650 creator A5085814306 @default.
• W3034988650 creator A5085853242 @default.
• W3034988650 date "2020-01-01" @default.
• W3034988650 modified "2023-10-03" @default.
• W3034988650 title "Preclinical evaluation of an ¹¹¹In/²²⁵Ac theranostic targeting transformed MUC1 for triple negative breast cancer" @default.
• W3034988650 cites W1537585009 @default.
• W3034988650 cites W1604624606 @default.
• W3034988650 cites W1959924590 @default.
• W3034988650 cites W1966335626 @default.
• W3034988650 cites W1986985221 @default.
• W3034988650 cites W1989686184 @default.
• W3034988650 cites W1992060814 @default.
• W3034988650 cites W2010901031 @default.
• W3034988650 cites W2037314771 @default.
• W3034988650 cites W2055191735 @default.
• W3034988650 cites W2070327519 @default.
• W3034988650 cites W2079422118 @default.
• W3034988650 cites W2080134708 @default.
• W3034988650 cites W2082318061 @default.
• W3034988650 cites W2089525226 @default.
• W3034988650 cites W2097512974 @default.
• W3034988650 cites W2100718450 @default.
• W3034988650 cites W2102509488 @default.
• W3034988650 cites W2106506685 @default.
• W3034988650 cites W2107931058 @default.
• W3034988650 cites W2116012295 @default.
• W3034988650 cites W2116798103 @default.
• W3034988650 cites W2134121541 @default.
• W3034988650 cites W2160195674 @default.
• W3034988650 cites W2165567204 @default.
• W3034988650 cites W2310832560 @default.
• W3034988650 cites W2467018059 @default.
• W3034988650 cites W2478491286 @default.
• W3034988650 cites W2509216739 @default.
• W3034988650 cites W2606353760 @default.
• W3034988650 cites W2789314441 @default.
• W3034988650 cites W2801430183 @default.
• W3034988650 cites W2804880486 @default.
• W3034988650 cites W2954795217 @default.
• W3034988650 doi "https://doi.org/10.7150/thno.38236" @default.
• W3034988650 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7295045" @default.
• W3034988650 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32550914" @default.
• W3034988650 hasPublicationYear "2020" @default.
• W3034988650 type Work @default.
• W3034988650 sameAs 3034988650 @default.
• W3034988650 citedByCount "26" @default.
• W3034988650 countsByYear W30349886502020 @default.
• W3034988650 countsByYear W30349886502021 @default.
• W3034988650 countsByYear W30349886502022 @default.
• W3034988650 countsByYear W30349886502023 @default.
• W3034988650 crossrefType "journal-article" @default.
• W3034988650 hasAuthorship W3034988650A5006550201 @default.
• W3034988650 hasAuthorship W3034988650A5023904129 @default.
• W3034988650 hasAuthorship W3034988650A5031651482 @default.
• W3034988650 hasAuthorship W3034988650A5032595840 @default.
• W3034988650 hasAuthorship W3034988650A5034046647 @default.
• W3034988650 hasAuthorship W3034988650A5035756167 @default.
• W3034988650 hasAuthorship W3034988650A5045937236 @default.
• W3034988650 hasAuthorship W3034988650A5062378220 @default.
• W3034988650 hasAuthorship W3034988650A5085814306 @default.
• W3034988650 hasAuthorship W3034988650A5085853242 @default.
• W3034988650 hasBestOaLocation W30349886501 @default.
• W3034988650 hasConcept C121608353 @default.
• W3034988650 hasConcept C126322002 @default.
• W3034988650 hasConcept C2777421810 @default.
• W3034988650 hasConcept C2780110267 @default.
• W3034988650 hasConcept C502942594 @default.
• W3034988650 hasConcept C530470458 @default.
• W3034988650 hasConcept C71924100 @default.
• W3034988650 hasConceptScore W3034988650C121608353 @default.
• W3034988650 hasConceptScore W3034988650C126322002 @default.
• W3034988650 hasConceptScore W3034988650C2777421810 @default.
• W3034988650 hasConceptScore W3034988650C2780110267 @default.
• W3034988650 hasConceptScore W3034988650C502942594 @default.
• W3034988650 hasConceptScore W3034988650C530470458 @default.
• W3034988650 hasConceptScore W3034988650C71924100 @default.
• W3034988650 hasIssue "15" @default.
• W3034988650 hasLocation W30349886501 @default.
• W3034988650 hasLocation W30349886502 @default.
• W3034988650 hasLocation W30349886503 @default.
• W3034988650 hasOpenAccess W3034988650 @default.
• W3034988650 hasPrimaryLocation W30349886501 @default.
• W3034988650 hasRelatedWork W1981888684 @default.
• W3034988650 hasRelatedWork W2043165423 @default.
• W3034988650 hasRelatedWork W2347642057 @default.
• W3034988650 hasRelatedWork W2348200754 @default.
• W3034988650 hasRelatedWork W2381807286 @default.
• W3034988650 hasRelatedWork W2385638496 @default.

• next